Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...

De dna-gegevens van miljoenen gebruikers van dna-testdienst 23andMe zijn verkocht aan het TTAM Research Institute en komen toch niet in handen van farmabedrijf Regeneron. Het instituut wordt geleid do ...

De deal kwam voort uit een competitief biedingsproces tussen TTAM en Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), waarbij het bod van TTAM het eerdere bod van Regeneron van $ 256 mln. overtrof. De ...

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...

23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...

Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...

Anne Wojcicki, de oprichter en ex-ceo van 23andMe gaat het failliete Amerikaanse dna-bedrijf opkopen. Wojcicki’s non-profitorganisatie TTAM krijgt alle activa van 23andMe in handen, inclusief de datab ...

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing ...

TTAM Research Institute, a nonprofit public benefit corporation based in California and led by 23andMe co-founder and former ...

Genetic testing firm 23andMe has been fined £2.31 million by the UK's data protection watchdog for "serious security failings ...

The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.